OptraScan Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$30M
- Investors
-
2
OptraScan General Information
Description
Developer of pathology system designed to scan and analyze tissue. The company's technology serves as a tool for the transition from conventional microscopy to digital pathology for the effective acquisition of whole slide images, viewing, sharing, analyzing, and management of digital slides and associated metadata, enabling labs to deliver integrated digital pathology solutions that maximize quality and efficiency.
Contact Information
Website
www.optrascan.comCorporate Office
- 2001 Gateway Place
- Suite 150W
- San Jose, CA 95110
- United States
Corporate Office
- 2001 Gateway Place
- Suite 150W
- San Jose, CA 95110
- United States
OptraScan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 06-Nov-2024 | $30M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series A) | 16-Mar-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 18-Oct-2016 | $3.75M | $3.75M | Completed | Generating Revenue |
OptraScan Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 382,054 | $0.19 | $3.14 | $3.14 | 1x | $3.14 | 1.31% | |
| Series A | 4,900,000 | $0.19 | $1.02 | $1.02 | 1x | $1.02 | 16.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
OptraScan Comparisons
Industry
Financing
Details
OptraScan Competitors (15)
One of OptraScan’s 15 competitors is Medic Vision Imaging Solutions, a Venture Capital-Backed company based in Tirat Carmel, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medic Vision Imaging Solutions | Venture Capital-Backed | Tirat Carmel, Israel | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Visiopharm | Private Equity-Backed | Hoersholm, Denmark | ||||
| microDimensions | Formerly VC-backed | Cloppenburg, Germany | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL |
OptraScan Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
OptraScan Patents
OptraScan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11315251-B2 | Method of operation of an artificial intelligence-equipped specimen scanning and analysis unit to digitally scan and analyze pathological specimen slides | Active | 19-Apr-2019 | ||
| US-20200334814-A1 | Method of operation of an artificial intelligence-equipped specimen scanning and analysis unit to digitally scan and analyze pathological specimen slides | Active | 19-Apr-2019 | ||
| US-10586376-B2 | Automated method of predicting efficacy of immunotherapy approaches | Active | 13-Jun-2017 | ||
| US-20180357816-A1 | Automated method of predicting efficacy of immunotherapy approaches | Active | 13-Jun-2017 | ||
| US-10338365-B2 | Slide storage, retrieval, transfer, and scanning system for a slide scanner | Active | 24-Aug-2016 | G02B21/002 |
OptraScan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
OptraScan Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Molbio Diagnostics | Corporation | Minority | ||
| NantOmics | Corporation | Minority |
OptraScan FAQs
-
When was OptraScan founded?
OptraScan was founded in 2014.
-
Where is OptraScan headquartered?
OptraScan is headquartered in San Jose, CA.
-
What is the size of OptraScan?
OptraScan has 63 total employees.
-
What industry is OptraScan in?
OptraScan’s primary industry is Diagnostic Equipment.
-
Is OptraScan a private or public company?
OptraScan is a Private company.
-
What is the current valuation of OptraScan?
The current valuation of OptraScan is .
-
What is OptraScan’s current revenue?
The current revenue for OptraScan is .
-
How much funding has OptraScan raised over time?
OptraScan has raised $52.2M.
-
Who are OptraScan’s investors?
Molbio Diagnostics and NantOmics have invested in OptraScan.
-
Who are OptraScan’s competitors?
Medic Vision Imaging Solutions, Ibex Medical Analytics, Visiopharm, microDimensions, and Tempus AI are some of the 15 competitors of OptraScan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
